Subclavian central venous catheter-related thrombosis in trauma patients: incidence, risk factors and influence of polyurethane type

Gentile, Ariane; Petit, Laurent; Masson, F.; Cottenceau, Vincent; Bertrand-Barat, J.; Freyburger, G.; Pinaquy, C.; Léger, A.; Cochard, J.F.; Sztark, F.

doi:10.1186/cc12748

Cited by 13 publications

(8 citation statements)

References 36 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a previous study, age was related to CVC-related thrombosis, 2,15 consistent with the present results. Age is a well-known risk factor for thrombosis because of poor circulation, poorer venous valve function, and decreased physical activity.…”

Section: Discussionsupporting

confidence: 93%

Assessment of thrombosis in right internal jugular vein after percutaneous superior vena cava catheter insertion during cardiovascular surgery with cardiopulmonary bypass

Rhee

Yoon

et al. 2016

The Journal of Thoracic and Cardiovascular Surgery

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 93%

Assessment of thrombosis in right internal jugular vein after percutaneous superior vena cava catheter insertion during cardiovascular surgery with cardiopulmonary bypass

Rhee

Yoon

et al. 2016

The Journal of Thoracic and Cardiovascular Surgery

View full text Add to dashboard Cite

show abstract

“…Results of studies on dealing with the effect of transfusion therapy and the presence of infection on the frequency of CR-DVT are ambiguous 9,16,[19][20][21] . In our study, we did not observe any relation between transfusion therapy, the presence of infection and a higher incidence of CR-DVT.…”

Section: Discussionmentioning

confidence: 99%

Central venous catheter-related thrombosis in intensive care patients - incidence and risk factors: A prospective observational study

Hrdý¹,

Straževská²,

Suk³

et al. 2017

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub

View full text Add to dashboard Cite

Background. One of the complications associated with central venous catheter (CVC) placement is catheter related deep vein thrombosis (CR-DVT). However a literature search revealed little evidence of this recognised complication. The primary aim of this study was to establish the incidence rate and risk factors for the development of CR-DVT in our critically ill adult patients. Methods. All critically ill adult patients admitted to the medical-surgical ICU with CVC inserted were included in this observational prospective study. After catheter removal we performed duplex ultrasound examination to assess the patency of the vein and establish if CR-DVT was present. Results. A total number of 308 catheters met the inclusion criteria of which 198 were included in the statistical analysis. The CVC was inserted into a subclavian vein (SCV) in 139 (70%) cases and in an internal jugular vein (IJV) in 59 (30%) cases. The 28-day mortality rate was 14.1%. We found CR-DVT during duplex ultrasound examination in 47 (26%) of all cases. 33 (70%) of the CR-DVT were diagnosed in the IJV and 14 (30%) in the SCV. The risk factors for the development of CR-DVT we identified included cannulation of the IJV and the use of treatment dose of LMWH. The effect of CR-DVT on 28-day mortality was not statistically significant. Conclusion. The risk factors for CR-DVT we identified were IJV as a site for CVC cannulation and the use of therapeutic anticoagulation prior to cannulation. Our recommendation would be preferential cannulation of a subclavian vein as opposed to an internal jugular vein in order to reduce the risk of CR-DVT.

show abstract

“…Home parenteral nutrition requires permanent central venous access for intravenous administration of PN solution, which represents an independent risk factor for catheter‐related thrombosis (CRT) in patients with a central venous access because of its composition and high osmolarity . Recurrent CRT is one of the most common complications and may trigger bacterial infections, sepsis, pulmonary embolism or vena cava syndrome, leading to a progressive loss of vascular access and the inability to further continue PN, with the need for intestinal transplantation .…”

Section: Introductionmentioning

confidence: 99%

Home parenteral nutrition‐associated thromboembolic and bleeding events: results of a cohort study of 236 individuals

Barco

Heuschen

Salman

et al. 2016

Journal of Thrombosis and Haemostasis

View full text Add to dashboard Cite

Sparse or outdated studies focus on thrombotic and bleeding risk in home parenteral nutrition (HPN). 236 HPN patients followed at a single center for a total of 684 patient‐years were evaluated. Rates of venous thrombosis and major bleeding, and prevalence of vena cava syndrome are provided. Anticoagulants might reduce thrombosis risk, but population‐specific safety concerns remain. Summary BackgroundHome parenteral nutrition (HPN) is necessary for patients with intestinal failure. Recurrent catheter‐related thrombosis (CRT) is common, leading to infectious complications, pulmonary embolism, vascular access loss and intestinal transplantation. The efficacy and safety of anticoagulants are unknown in this setting and based on sparse and low‐quality observational data. ObjectivesOur aim was to estimate the incidence of thromboembolic, bleeding and anticoagulant‐related complications in HPN patients, and evaluate risk factors for first venous thrombosis (VT). MethodsThis retrospective cohort study included all adult patients followed for long‐term HPN at our center between 1986 and 2014. Primary outcomes were symptomatic objectively diagnosed VT, encompassing CRT and venous thromboembolism, and major bleeding. Secondary outcomes were vena cava syndrome and heparin‐induced thrombocytopenia or hypersensitivity. ResultsA total of 236 patients were included (median HPN duration, 17 months) and 136 received anticoagulants at HPN onset (57.6%). Overall, the annual incidence of first VT was 11.4% (95% confidence interval [95% CI], 8.6–14.7%); VT was associated with a personal history of thrombosis (adjusted hazard ratio, 2.22; 95% CI, 1.06–4.64), whereas anticoagulation seemed to account only for a mild protection (adjusted hazard ratio, 0.72; 95% CI, 0.36–1.44). The annual incidence of major bleeding was 4.3% for patients on anticoagulants vs. 1.8% for those off anticoagulants. Vena cava syndrome developed in 20.7% of patients with VT. One patient had isolated heparin‐induced thrombocytopenia (0.6%) and four had heparin hypersensitivity (2.5%). ConclusionsPatients on HPN have a significant risk of venous thrombosis, major bleeding and vena cava syndrome. Anticoagulants might reduce thrombosis risk, but population‐specific safety concerns remain.

show abstract

Subclavian central venous catheter-related thrombosis in trauma patients: incidence, risk factors and influence of polyurethane type

Cited by 13 publications

References 36 publications

Assessment of thrombosis in right internal jugular vein after percutaneous superior vena cava catheter insertion during cardiovascular surgery with cardiopulmonary bypass

Assessment of thrombosis in right internal jugular vein after percutaneous superior vena cava catheter insertion during cardiovascular surgery with cardiopulmonary bypass

Central venous catheter-related thrombosis in intensive care patients - incidence and risk factors: A prospective observational study

Home parenteral nutrition‐associated thromboembolic and bleeding events: results of a cohort study of 236 individuals

Contact Info

Product

Resources

About